Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
This page is not indexed by search engines while we improve data quality.
Immatics Biotechnologies Gmbh — Physics
Immatics Biotechnologies Gmbh holds 1,100 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Immatics Biotechnologies Gmbh |
| Technology | Physics |
| Patents in slice | 1,100 |
| Recent patents in slice | 174 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Immatics Biotechnologies Gmbh to Physics.
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Recent filings
Latest patents from Immatics Biotechnologies Gmbh in Physics.
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Peptides and combination of peptides for use in immunotherapy against cancers
US-2026042828-A1 · Feb 12, 2026 · US
Related pages
Navigate to parent entity pages.